Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1199797-41-5Ertapenem Dimer Form D Impurity

● In Stock

Catalogue No.:	VE0011023
CAS No.:	1199797-41-5
Mol. Formula:	C44H50N6O14S2
Mol. Weight:	951.03 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 1199797-41-5

Parent drug

Ertapenem

IUPAC Name

(4R, 5S, 6S)-3-((3S, 5S)-1-((3R)-2-((3R)-4-((3S, 5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-5-carboxy-3-methyl-3, 4-dihydro-2H-pyrrol-2-yl)-3-hydroxybutanoyl)-5-((3-carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid

Synonyms

Ertapenem Dimer 1;Ertapenem Dimer I;Ertapenem Impurity 3;ErtapeneM DiMer ForM D IMpurity;1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[(3S,5S)-1-[(2S,3R)-2-[(2S,3R)-5-carboxy-4-[[(3S,5S)-5-[[(3-carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-3,4-dihydro-3-methyl-2H-pyrrol-2-yl]-3-hydroxy-1-oxobutyl]-5-[[(3-carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyeth..